Cite
HARVARD Citation
Scott, R. et al. (2018). A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT‐R study. Diabetes, obesity & metabolism. 20 (12), pp. 2876-2884. [Online].